FindMyKOL
Clinical trialNCT02451124CompletedInterventional

Non-endoscopic Brushing of the Esophagus Using a Non-endoscopic Inflatable Balloon of the Esophagus in Screening for Barrett Esophagus

NCT02451124 is an interventional trial sponsored by Case Comprehensive Cancer Center. As of 21 Nov 2026, it is completed. It studies Barrett Esophagus. The registry lists an enrollment of 156 participants at 2 sites in 1 country. The registry lists a start date of 31 Jul 2015 and a primary completion date of 11 Aug 2016. One of its registered investigators has a FindMyKOL profile.

SponsorCase Comprehensive Cancer Center →Enrollment156Barrett Esophagus
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02451124
FieldValue
Registry IDNCT02451124
StatusCompleted
Study typeInterventional trial
Lead sponsorCase Comprehensive Cancer Center
Enrollment156
Registered sites2
Countries1
ConditionsBarrett Esophagus
Start31 Jul 2015
Primary completion11 Aug 2016
Study completion29 Jan 2017
Last update posted6 Nov 2019

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This pilot clinical trial studies non-endoscopic brushing of the esophagus using a non-endoscopic inflatable balloon for the esophagus in screening for Barrett esophagus, a condition where the lining of the esophagus has changed or been replaced with abnormal cells that may lead to cancer. The non-endoscopic inflatable balloon for the esophagus is a capsule balloon that brushes against the walls of the esophagus to collect esophageal samples. Non-endoscopic brushing of the esophagus using a non-endoscopic inflatable balloon for the esophagus may help doctors find Barrett esophagus sooner, when it may be easier to treat.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States2 sites
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

    Cleveland

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 2 sitesOH2PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02451124

Each answer restates registry values shown on this page.

What is NCT02451124?

NCT02451124 is an interventional trial sponsored by Case Comprehensive Cancer Center. It studies Barrett Esophagus.

Who leads NCT02451124?

The registry names Amitabh Chak (principal investigator, Case Comprehensive Cancer Center) as the overall official.

Where does NCT02451124 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT02451124 end?

The registry lists a primary completion date of 11 Aug 2016 and a study completion date of 29 Jan 2017. The sponsor last updated the record on 6 Nov 2019.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.